Tuning Silica Nanoparticles for Cell Specific Biotargeting
News Jun 22, 2009
Researchers from Abo Akademi University and the University of Turku in Finland have discovered that the stability of functionalized nanoparticles is crucially dependent on all functional groups present on the surface.
Using the sensitive nanoscale particle sizing and zeta potential measurement capabilities of a Zetasizer Nano from Malvern Instruments, they showed that poly (ethylene imine) (PEI) functionalized silica particles made promising candidates for bioapplications. This research has now led to the development of a selective nanoparticulate system for cancer cell targeting.
One of the key aims in biomedical science is to develop applications that can target and deliver drug to specific cell populations. Porous, non-toxic silica based structures have potential as biocompatible vehicles for intracellular delivery of an active ingredient.
However, any modification to the original particle structure, such as the addition of an imaging agent, surface coating or a targeting agent, changes both its size and surface charge. This leads to changes in the stability of the particulate system.
Using both particle sizing using dynamic light scattering (DLS) and zeta potential measurements with a Zetasizer Nano, the Finnish research team showed both direct and indirect effects on the suspension stability of functionalized silica particles as a result of surface modification. These results were published in the Journal of Nanomaterials in 2008.
The team then went on, publishing results in ACS Nano in 2009 that used similar techniques to develop a multifunctional nanodevice for cancer therapy that demonstrated remarkably good cell specificity.
The size, stability and cell specificity of functionalized nanoparticles for targeted drug delivery is crucially dependent on each surface modification as well as the overall surface charge. Besides the fact that surface charge along with particle size are directly decisive for a nanoparticles’ biodistribution, other highly critical factors, such as cytotoxicity and the efficiency of cellular uptake, are associated with nanoparticle size.
While the technique of dynamic light scattering (DLS) is ideally suited for the determination of particle size, zeta potential measurements indicate the repulsive force that is present and can be used to predict the long-term stability of the product.
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Nanomedicine and Nanotechnology
Aug 20 - Aug 21, 2018